GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » EBITDA Margin %

Anti-Microbialvior BioteQ Co (ROCO:6864) EBITDA Margin % : -14,092.13% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Anti-Microbialvior BioteQ Co's EBITDA for the six months ended in Dec. 2024 was NT$-37.63 Mil. Anti-Microbialvior BioteQ Co's Revenue for the six months ended in Dec. 2024 was NT$0.27 Mil. Therefore, Anti-Microbialvior BioteQ Co's EBITDA margin for the quarter that ended in Dec. 2024 was -14,092.13%.


Anti-Microbialvior BioteQ Co EBITDA Margin % Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co EBITDA Margin % Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial -15,527.40 -22,292.05 -1,118.80 -6,352.20 -10,403.43

Anti-Microbialvior BioteQ Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,426.52 -3,778.88 -13,485.49 -7,548.70 -14,092.13

Competitive Comparison of Anti-Microbialvior BioteQ Co's EBITDA Margin %

For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anti-Microbialvior BioteQ Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Anti-Microbialvior BioteQ Co's EBITDA Margin % falls into.


;
;

Anti-Microbialvior BioteQ Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Anti-Microbialvior BioteQ Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-63.669/0.612
=-10,403.43 %

Anti-Microbialvior BioteQ Co's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-37.626/0.267
=-14,092.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anti-Microbialvior BioteQ Co  (ROCO:6864) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Anti-Microbialvior BioteQ Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Anti-Microbialvior BioteQ Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Siwei 3rd Road, 7th Floor-2, Lingya District, Kaohsiung, TWN, 741
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co Headlines

No Headlines